SA's Premier Group Suspends UPD Listing

25 September 1994

Premier Group, one of the largest food and industrial groups in South Africa, has requested the Johannesburg Stock Exchange to temporarily suspend the listing of its subsidiary Wholesale Pharmaceutical Holdings Limited (WPH). This follows severe financial losses by United Pharmaceutical Distributors (UPD), a company in which WPH has an interest of 51%, due to alleged fraud and mismanagement.

WPH merged its wholesale pharmaceutical interests with those of Medical Cash and Carry (Pty) Ltd in 1993 to form UPD. Norman Knight, who previously controlled MCC, was appointed executive chairman of UPD at the time.

Premier and WPH said in a statement to shareholders that ongoing investigations suggest that Mr Knight and certain of his associates have been involved in activities unacceptable to WPH. As moneys have been misappropriated, a formal complaints has been lodged with the Attorney General, alleging several charges of fraud and theft totalling approximately 40 million rand ($11.3 million), reports the Marketletter's local correspondent.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight